RETRACTED: Proteomics-Based Identification of Α-Enolase as a Potential Prognostic Marker in Cholangiocarcinoma

Clinical Biochemistry - Netherlands
doi 10.1016/j.clinbiochem.2012.04.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Unlikely Role of Glycolytic Enzyme Α-Enolase in Cancer Metastasis and Its Potential as a Prognostic Biomarker

Journal of Cancer Metastasis and Treatment
2020English

Mass-Forming Intrahepatic Cholangiocarcinoma: Diffusion-Weighted Imaging as a Preoperative Prognostic Marker

Radiology
Nuclear MedicineRadiologyImaging
2016English

Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma

Oncotarget
Oncology
2015English

The Utility of Keratin 903 as a New Prognostic Marker in Mass-Forming-Type Intrahepatic Cholangiocarcinoma

Modern Pathology
Forensic MedicinePathology
2002English

Identification of TPD52 and DNAJB1 as Two Novel Bile Biomarkers for Cholangiocarcinoma by iTRAQ‑based Quantitative Proteomics Analysis

Oncology Reports
MedicineCancer ResearchOncology
2019English

Transcriptomic Analysis and Identification of Prognostic Biomarkers in Cholangiocarcinoma

Oncology Reports
MedicineCancer ResearchOncology
2019English

Epithelial Protein Lost in Neoplasm-Α (EPLIN-α) Is a Potential Prognostic Marker for the Progression of Epithelial Ovarian Cancer

International Journal of Oncology
Cancer ResearchOncology
2016English

Neurone Specific Enolase (NSE) in Small Cell Lung Cancer: A Tumour Marker of Prognostic Significance?

British Journal of Cancer
Cancer ResearchOncology
1990English

RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer

Clinical and Investigative Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy